To what extent will flow-diverting devices be adopted in the European regions covered in this report? Find out that and more by requesting a Free Sample today.
The European market for TEO devices is a dynamic and complex market driven by continual device improvement and adoption of new, innovative products.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for TEO devices in Europe across a 10-year period.
Millennium Research Group has up-to-date reports on a wide range of medical device markets worldwide.
* The INR flow-diverting device market will be the fastest growing market over the forecast period.
How will the unexplained mortality risks associated with this procedure affect adoption of this device?
How will the markets for INR embolization coils and INR coiling-assist devices be impacted?
* The fastest procedure volume growth in Europe will take place in the peripheral tumor indication.
What factors will contribute to the adoption of radioembolization spheres and drug-eluting beads for the treatment of HCC and metastatic CRC?
How will the NHS' new Commissioning through Evaluation programme affect reimbursement for radioembolization spheres in the UK?
How will adoption of these devices affect PVA particle and microsphere procedure volumes?
* Unfavorable referral patterns have negatively impacted UFE procedure volumes in the past.
How will microsphere and PVA particle procedural growth be affected?
How will the breakdown between PVA particle and microsphere use differ throughout Europe for this indication?
How can competitors in the embolization particle market prevent similar unfavorable referral patterns from affecting the relatively newer PAE procedure?(The Contents on this Website is a Condensed Version of the Original Report. To View the Complete Version, Please Request a Sample.)
Browse more Catheter Equipment Market Research Reports